Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Colorado guideColorado Bids and Bidding Guide
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Colorado
  4. ›Healthcare and Medical Services
  5. ›Twist Bioscience Reagents

Colorado Department of Public Health and Environment (CDPHE)·Colorado

Twist Bioscience Reagents

Closes 5/22/2026$2M – $3MSole Source
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Colorado Department of Public Health and Environment (CDPHE) is seeking to procure Twist Bioscience Reagents, specifically synthetic viral pathogen controls, from Twist Biosciences. The controls are necessary for the CDPHE's Genomic Surveillance Program, Sequencing and Wastewater Unit, to assess the efficacy of quantitative RT-PCR, dPCR, NGS, or equivalent tests. The sole source justification is based on the fact that Twist Biosciences is the only vendor that can supply the required high-fidelity, high-throughput, assay-ready, verified, sequence published, synthetic whole genome DNA/RNA viral controls. The procurement is for a 5-year term, with an estimated total cost of $2.3 million. • The required products are synthetic viral pathogen controls and custom Hyb Cap panels. • The controls must be high-fidelity, assay-ready, whole genome, sequence published, lot traceable, and verified. • The Hyb Cap panel targets and customizable probes must be compatible with the existing sequencing infrastructure and workflow. • The vendor must have the capability to produce and sell assay-ready verified synthetic controls. • The procurement is for a 5-year term, with an estimated total cost of $2.3 million.

Attached files

Contact

Kristi Gamble(Buyer)

[email protected]

Key dates

Opened
5/19/2026
Closes
5/22/2026
Duration
5 years

Last updated

Details

Type
Sole Source
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
NPSS1-FHCA-2026000209-1

Budget estimate

$2,000,000 – $3,000,000

Based on the document, the estimated total cost of the procurement is $2.3 million over a 5-year term. This estimate is based on the cost of the synthetic viral pathogen controls and custom Hyb Cap panels, as well as the cost of any additional services or support required. The cost is considered fair and reasonable, given the unique requirements of the procurement and the lack of alternative vendors. Factors that may influence the likely payment range include the cost of raw materials, labor, and overhead, as well as the complexity of the manufacturing process.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Department Of Energy·Ohio

Top match · 63%

TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs Platform

Closes 12/15/2026Opened 6/15/2026

U.S. National Institutes of Health·United States of America

63% match

Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)

Closes 12/23/2027Opened 11/22/2024

U.S. Department Of Energy·Ohio

62% match

TECHNOLOGY LICENSING OPPORTUNITY: Protein-Based Rare Earth Recovery via Condensation

Closes 12/22/2026Opened 6/22/2026

U.S. Department Of Health And Human Services·Maryland

62% match

Reagents and consumables for Roche immunostainers

Closes 11/16/2026Opened 10/30/2026

U.S. National Institutes of Health·United States of America

62% match

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Closes 6/15/2027Opened 9/25/2024

U.S. National Institutes of Health·United States of America

62% match

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

Closes 12/23/2027Opened 11/22/2024

U.S. National Institutes of Health·United States of America

62% match

Transformative Technologies for Experimental and Computational RNome Characterization and Functional Analysis

Closes 2/14/2027Opened 8/5/2026

U.S. Department Of Energy·Ohio

62% match

TECHNOLOGY LICENSING OPPORTUNITY: SurfGraphPro

Closes 12/5/2026Opened 6/5/2026

U.S. National Institutes of Health·United States of America

62% match

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Closes 9/10/2027Opened 12/13/2024

U.S. Department Of Veterans Affairs·Texas

61% match

6550--Blood Bank Reagents

Closes 11/5/2026Opened 10/28/2026

U.S. Department Of Energy·Ohio

61% match

TECHNOLOGY LICENSING OPPORTUNITY: SignalGen

Closes 3/22/2027Opened 9/22/2026

U.S. National Science Foundation·United States of America

61% match

A Science of Science Approach to Analyzing and Innovating the Biomedical Research Enterprise (SoS:BIO)

Closes 2/9/2027Opened 3/21/2023

U.S. National Institutes of Health·United States of America

61% match

Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)

Closes 12/23/2027Opened 11/22/2024

U.S. Department Of Defense·United States of America

61% match

Non-Optical Methods for High Speed Protein Control

Closes 12/31/2026Opened 7/21/2026

U.S. Department Of Energy·Ohio

61% match

TECHNOLOGY LICENSING OPPORTUNITY: PFAS-Free Sulfonated Poly(norbornene) Ionomeric Binders

Closes 1/6/2027Opened 6/29/2026

U.S. Food and Drug Administration·United States of America

61% match

Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. Department Of Energy·New Mexico

61% match

TIDAL: Target-Induced Droplet Assembly of Ligands

Closes 12/8/2026Opened 9/8/2026

U.S. Department Of Energy·New Mexico

60% match

TECHNOLOGY LICENSING OPPORTUNITY: GreenFuran Direct Allylation

Closes 2/12/2027Opened 8/12/2026

U.S. Department Of Defense·Maryland

60% match

Notice of Intent DNA Synthesizer

Closes 11/2/2026Opened 10/15/2026

U.S. Department Of Health And Human Services·Indiana

60% match

NOI - B2B Award entitled - Developing Red Cell-Sp

Closes 11/4/2026Opened 10/20/2026

U.S. Department Of Veterans Affairs·Washington

60% match

Purchase of Rapid Syndromic Molecular Testing Reagents for Seattle VAMC

Closes 8/6/2027Opened 7/30/2026

University of Texas MD Anderson Cancer Center·Texas

60% match

Discovery and Development of Small Molecules and Biologic Therapies RFP

Closes 12/9/2026Opened 10/30/2026

U.S. National Institutes of Health·United States of America

60% match

Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)

Closes 2/15/2028Opened 9/16/2026

U.S. National Institutes of Health·United States of America

60% match

Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)

Closes 9/7/2027Opened 3/8/2022

U.S. Department Of Veterans Affairs·California

60% match

6550--Blood Type IVD Reagents

Closes 11/16/2026Opened 10/30/2026